Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO12089 | Trifolium alexandrinum | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO14845 | Ceratophyllum submersum | Species | Ceratophyllaceae | Eukaryota | UNPD* | |||
NPO24173 | Plutella xylostella | Species | Plutellidae | Eukaryota | UNPD* | |||
NPO10818 | Carpobrotus edulis | Species | Aizoaceae | Eukaryota | UNPD* | |||
NPO20617 | Tilletia laevis | Species | Tilletiaceae | Eukaryota | UNPD* | |||
NPO22583 | Daedaleopsis confragosa | Species | Coriolaceae | Eukaryota | UNPD* | |||
NPO18557 | Epicoccum nigrum | Species | Didymellaceae | Eukaryota | UNPD* | |||
NPO29598 | Mahoniae caulis | NA | NA | NA | TCMSP* | |||
NPO15520 | Dracocephalum kotschyi | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO16472 | Ginkgo semen | Species | Ginkgoaceae | Eukaryota | TCMSP* | |||
NPO14749 | Lippia carviodora | Species | Verbenaceae | Eukaryota | UNPD* | |||
NPO11995 | Mahoniae eadix | NA | NA | NA | TCMSP* | |||
NPO211 | Aplysina cauliformis | Species | Aplysinidae | Eukaryota | UNPD* | |||
NPO9158 | Mahoniae folum | NA | NA | NA | TCMSP* | |||
NPO1641 | Amycolatopsis azurea | Species | Pseudonocardiaceae | Bacteria | UNPD* | |||
NPO29653 | Hippophae fructus | Species | Elaeagnaceae | Eukaryota | TCMSP* | |||
NPO7952 | Commelina communis | Species | Commelinaceae | Eukaryota | TCMID* | |||
NPO12717 | Parmelia metastrigosa | Species | Parmeliaceae | Eukaryota | UNPD* | |||
NPO29695 | Gleditsiae spina | NA | NA | NA | TCMSP* | |||
NPO3381 | Swertia hickinii | Species | Gentianaceae | Eukaryota | TCMID* | |||
NPO11873 | Oecophylla smaragdina | Species | Formicidae | Eukaryota | UNPD* | |||
NPO28993 | Streptomyces venezuelae | Species | Streptomycetaceae | Bacteria | StreptomeDB* | |||
NPO27617 | Phoenix dactylifera | Species | Arecaceae | Eukaryota | TCMID* | |||
NPO24045 | Lespedeza homoloba | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO28574 | Oroxylum indicum | Species | Bignoniaceae | Eukaryota | TCMID* | |||
NPO24329 | Primula farinosa | Species | Primulaceae | Eukaryota | UNPD* | |||
NPO2013 | Herba desmodii styracifolii | NA | NA | NA | TCMID* | |||
NPO15440 | Chamaemelum nobile | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO14548 | Ilex rotunda | Species | Aquifoliaceae | Eukaryota | TCMID* | |||
NPO11637 | Psilostrophe cooperi | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO20484 | Radix tetrastigmatis hemsleyani | Species | Lymnaeidae | Eukaryota | TCMID* | |||
NPO17647 | Schkuhria multiflora | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO22303 | Rhizoma paridis | NA | NA | NA | TCMID* | |||
NPO14548 | Ilex rotunda | Species | Aquifoliaceae | Eukaryota | HerDing* | |||
NPO27414 | Folium aconiti szechenyiani | NA | NA | NA | TCMID* | |||
NPO21813 | Primula pulverulenta | Species | Primulaceae | Eukaryota | HerDing* | |||
NPO3292 | Desmodium styracifolium | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO27617 | Phoenix dactylifera | Species | Arecaceae | Eukaryota | TCM_Taiwan* | |||
NPO21813 | Primula pulverulenta | Species | Primulaceae | Eukaryota | TCMID* | |||
NPO27617 | Phoenix dactylifera | Species | Arecaceae | Eukaryota | HerDing* | |||
NPO27662 | Pericarpium citri reticulatae viride | NA | NA | NA | TCMID* | |||
NPO28574 | Oroxylum indicum | Species | Bignoniaceae | Eukaryota | HerDing* | |||
NPO1084 | Hemerocallis minor | Species | Asphodelaceae | Eukaryota | TCMID* | |||
NPO31462 | Folium aconiti | NA | NA | NA | HerDing* | |||
NPO3292 | Desmodium styracifolium | Species | Fabaceae | Eukaryota | HerDing* | |||
NPO7952 | Commelina communis | Species | Commelinaceae | Eukaryota | HerDing* | |||
NPO14948 | Brucea javanica | Species | Simaroubaceae | Eukaryota | UNPD* | |||
NPO23916 | Anthocleista grandiflora | Species | Gentianaceae | Eukaryota | UNPD* | |||
NPO16234 | Orgyia australis postica | Species | Lymantriidae | Eukaryota | UNPD* | |||
NPO24216 | Lolium perenne | Species | Poaceae | Eukaryota | UNPD* | |||
NPO12944 | Sideritis tragoriganum | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO14528 | Pneumatospora obcoronata | NA | NA | NA | UNPD* | |||
NPO9203 | Cephalonomia gallicola | Species | Bethylidae | Eukaryota | UNPD* | |||
NPO11432 | Centrolobium tomentosum | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO15146 | Myrica nana | Species | Myricaceae | Eukaryota | UNPD* | |||
NPO11084 | Asplenium normale | Species | Aspleniaceae | Eukaryota | UNPD* | |||
NPO30745 | Chrysanthemum morifolium | Species | Asteraceae | Eukaryota |
PMID[8158164] |
|||
NPO3164 | Yponomeuta malinellus | Species | Yponomeutidae | Eukaryota | UNPD* | |||
NPO23957 | Helleborus caucasicus | Species | Ranunculaceae | Eukaryota | UNPD* | |||
NPO14150 | Solanum jamaicense | Species | Solanaceae | Eukaryota | UNPD* | |||
NPO5303 | Castanea crenata | Species | Fagaceae | Eukaryota | UNPD* | |||
NPO26718 | Chelidonura fulvipunctata | Species | Aglajidae | Eukaryota | UNPD* | |||
NPO24284 | Hypoestes serpens | Species | Acanthaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2553 | Individual Protein | Aminopeptidase N | Homo sapiens | Inhibition | = | 5 | % | 12930151 |
NPT2 | Others | Unspecified | Ki | = | 190 | nM | 7277387 | |
NPT2 | Others | Unspecified | Ki | = | 33 | nM | 7277387 | |
NPT805 | Protein Complex | GABA-A receptor; anion channel | Rattus norvegicus | Ki | = | 1000 | nM | 10.1016/S0960-894X(97)00343-0 |
NPT996 | Protein Complex | GABA-A receptor; anion channel | Homo sapiens | Ki | = | 1000 | nM | 11384234 |
NPT581 | Individual Protein | Cyclooxygenase-2 | Mus musculus | Inhibition | = | 92.2 | % | 14980657 |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 500 | nM | 14980657 |
NPT805 | Protein Complex | GABA-A receptor; anion channel | Rattus norvegicus | Ki | = | 4200 | nM | 10543878 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 3280 | nM | 8691424 |
NPT2554 | Protein Family | Adenosine A2 receptor | Rattus norvegicus | Ki | = | 3450 | nM | 8691424 |
NPT218 | Individual Protein | Adenosine A3 receptor | Homo sapiens | Ki | = | 16900 | nM | 8691424 |
NPT2555 | Others | Adenosine receptors; A1 & A3 | Rattus norvegicus | Ratio | = | 0.19 | 8691424 | |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 3280 | nM | 8576921 |
NPT1316 | Individual Protein | Adenosine A2a receptor | Rattus norvegicus | Ki | = | 3450 | nM | 8576921 |
NPT218 | Individual Protein | Adenosine A3 receptor | Homo sapiens | Ki | = | 16900 | nM | 8576921 |
NPT996 | Protein Complex | GABA-A receptor; anion channel | Homo sapiens | Ki | = | 17 | nM | 10508425 |
NPT805 | Protein Complex | GABA-A receptor; anion channel | Rattus norvegicus | Ki | = | 4200 | nM | 12213060 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 6.9 | mg/kg | 8523407 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED50 | = | 6.9 | mg/kg | 10.1016/0960-894X(96)00134-5 |
NPT2556 | Individual Protein | DNA-dependent protein kinase | Homo sapiens | IC50 | > | 10000 | nM | 15658870 |
NPT299 | Individual Protein | Androgen Receptor | Rattus norvegicus | IC50 | = | 77624.71 | nM | 16134935 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 60800 | nM | 16722653 |
NPT384 | Cell Line | TK-10 | Homo sapiens | Activity | = | 87 | % | 17383189 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 57 | % | 17383189 |
NPT139 | Cell Line | HT-29 | Homo sapiens | Activity | = | 90 | % | 17383189 |
NPT2 | Others | Unspecified | Activity | = | 14.5 | % | 2959755 | |
NPT2 | Others | Unspecified | Activity | = | 82 | % | 2959755 | |
NPT2 | Others | Unspecified | Activity | = | 67.4 | % | 2959755 | |
NPT2 | Others | Unspecified | IC50 | = | 240 | nM | 2959755 | |
NPT1310 | Individual Protein | Xanthine dehydrogenase | Bos taurus | Inhibition | = | 15.4 | % | 3379415 |
NPT285 | Individual Protein | Epidermal growth factor receptor erbB1 | Homo sapiens | IC50 | = | 50 | ug/ml | 1479375 |
NPT2 | Others | Unspecified | Activity | = | 6.8 | 8882428 | ||
NPT2557 | Organism | Dermatophagoides pteronyssinus | Dermatophagoides pteronyssinus | EC50 | = | 0.5 | g/m2 | 12762809 |
NPT759 | Cell Line | H9 | Homo sapiens | IC50 | = | 68000 | nM | 8158164 |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | = | 50000 | nM | 8158164 |
NPT1587 | Individual Protein | Estradiol 17-beta-dehydrogenase 1 | Homo sapiens | Activity | = | 94 | % | 18533708 |
NPT1588 | Individual Protein | Estradiol 17-beta-dehydrogenase 2 | Homo sapiens | Activity | = | 63.9 | % | 18533708 |
NPT2 | Others | Unspecified | IC50 | > | 10000 | nM | 19097788 | |
NPT2558 | Individual Protein | Dihydroorotate dehydrogenase | Plasmodium falciparum | IC50 | > | 10000 | nM | 19097788 |
NPT2559 | Individual Protein | Dihydroorotate dehydrogenase | Saccharomyces cerevisiae S288c | IC50 | > | 10000 | nM | 19097788 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 2 | nM | 19097788 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | > | 10000 | nM | 19097788 |
NPT2 | Others | Unspecified | IC50 | = | 166000 | nM | 10096854 | |
NPT2560 | Protein Family | Phosphodiesterase 4 | Homo sapiens | Inhibition | = | 50 | % | 10096854 |
NPT2560 | Protein Family | Phosphodiesterase 4 | Homo sapiens | Activity | = | 3.6 | nmol | 10096854 |
NPT2 | Others | Unspecified | IC50 | = | 287100 | nM | 10096863 | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | IC50 | = | 5900 | nM | 19592245 |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Ratio IC50 | = | 6.5 | 19592245 | |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | Inhibition | = | 40 | % | 20045650 |
NPT441 | Individual Protein | Cytochrome P450 19A1 | Homo sapiens | IC50 | = | 8 | nM | 20413308 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 10.8 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 10.6 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 19.5 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 32.76 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 0.05 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | -39.69 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | -21.41 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | -10.02 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 13.53 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | -11.65 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | -24.7 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | -21.56 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | -16.16 | % | 20346546 |
NPT1137 | Individual Protein | 11-beta-hydroxysteroid dehydrogenase 1 | Homo sapiens | Inhibition | = | 16 | % | 20346546 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 30 | % | 20639112 |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 3162.3 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 14125.4 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | CC50 | = | 34210 | nM | PubChem BioAssay data set | |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 5623.4 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 8912.5 | nM | PubChem BioAssay data set |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 5 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT2561 | Individual Protein | Triosephosphate isomerase, glycosomal | Trypanosoma cruzi | Inhibition | = | 83 | % | 20889239 |
NPT2561 | Individual Protein | Triosephosphate isomerase, glycosomal | Trypanosoma cruzi | Inhibition | = | 52 | % | 20889239 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | GI | = | 19.1 | % | 20889239 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | ID50 | > | 0.025 | nM | 20889239 |
NPT2 | Others | Unspecified | Ratio | > | 4 | 20889239 | ||
NPT177 | Tissue | Aorta | Rattus norvegicus | IC50 | = | 46000 | nM | 21129983 |
NPT177 | Tissue | Aorta | Rattus norvegicus | IC50 | = | 203000 | nM | 21129983 |
NPT1621 | Individual Protein | Calmodulin | Homo sapiens | IC50 | = | 102280 | nM | 21129983 |
NPT1621 | Individual Protein | Calmodulin | Homo sapiens | Ratio IC50 | = | 0.34 | 21129983 | |
NPT2 | Others | Unspecified | Kd | = | 1000000 | nM | 21183345 | |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 17000 | nM | 21354800 |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | IC50 | = | 26000 | nM | 21354800 |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 20587.8 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 14575 | nM | PubChem BioAssay data set | |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -5.2 | % | 21493073 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -6.8 | % | 21493073 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -2.6 | % | 21493073 |
NPT520 | Cell Line | 3T3-L1 | Mus musculus | Activity | = | -10.9 | % | 21493073 |
NPT188 | Organism | Candida parapsilosis | Candida parapsilosis | MIC | = | 200000 | nM | 21530273 |
NPT85 | Organism | Filobasidiella neoformans | Cryptococcus neoformans | MIC | = | 100000 | nM | 21530273 |
NPT21 | Organism | Aspergillus niger | Aspergillus niger | MIC | = | 800000 | nM | 21530273 |
NPT2 | Others | Unspecified | MIC | = | 100000 | nM | 21530273 | |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Kd | = | 33884.42 | nM | 21723648 |
NPT2 | Others | Unspecified | Inhibition | = | 113.49 | % | 21907578 | |
NPT546 | Individual Protein | Retinoid X receptor alpha | Homo sapiens | Potency | 3162.3 | nM | PubChem BioAssay data set | |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Potency | 1258.9 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 9285 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 3981.1 | nM | PubChem BioAssay data set | |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 3548.1 | nM | PubChem BioAssay data set | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 13115.4 | nM | PubChem BioAssay data set | |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 21331.3 | nM | PubChem BioAssay data set | |
NPT249 | Individual Protein | Glucocorticoid receptor | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT249 | Individual Protein | Glucocorticoid receptor | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT546 | Individual Protein | Retinoid X receptor alpha | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT35 | Others | n.a. | Ratio | = | 1.51 | 22197671 | ||
NPT35 | Others | n.a. | Ratio | = | 2.4 | 22197671 | ||
NPT2 | Others | Unspecified | Ratio | = | 0.2 | 22197671 | ||
NPT2 | Others | Unspecified | Ratio | = | 3.73 | 22197671 | ||
NPT2 | Others | Unspecified | Ratio | = | 2.72 | 22197671 | ||
NPT632 | Tissue | Brain | Rattus norvegicus | Activity | = | 0.78 | nmol | 22197671 |
NPT632 | Tissue | Brain | Rattus norvegicus | Activity | = | 0.87 | nmol | 22197671 |
NPT632 | Tissue | Brain | Rattus norvegicus | Activity | = | 0.83 | nmol | 22197671 |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 20923.5 | nM | PubChem BioAssay data set | |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 1890 | nM | 22487176 |
NPT947 | Individual Protein | Carbonic anhydrase I | Homo sapiens | Ki | = | 1880 | nM | 22487176 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 8710 | nM | 22487176 |
NPT233 | Individual Protein | Carbonic anhydrase II | Homo sapiens | Ki | = | 8800 | nM | 22487176 |
NPT948 | Individual Protein | Carbonic anhydrase IX | Homo sapiens | Ki | = | 4130 | nM | 22487176 |
NPT948 | Individual Protein | Carbonic anhydrase IX | Homo sapiens | Ki | = | 4220 | nM | 22487176 |
NPT949 | Individual Protein | Carbonic anhydrase XII | Homo sapiens | Ki | = | 7220 | nM | 22487176 |
NPT949 | Individual Protein | Carbonic anhydrase XII | Homo sapiens | Ki | = | 7330 | nM | 22487176 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 103.2 | nM | PubChem BioAssay data set | |
NPT155 | Individual Protein | Aryl hydrocarbon receptor | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT155 | Individual Protein | Aryl hydrocarbon receptor | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 4609 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 5448.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 31622.8 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 730.8 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT158 | Individual Protein | Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT158 | Individual Protein | Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus | Potency | 15848.9 | nM | PubChem BioAssay data set | |
NPT102 | Individual Protein | Interleukin-8 | Homo sapiens | Potency | 74978 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 33491.5 | nM | PubChem BioAssay data set | ||
NPT103 | Individual Protein | Nuclear receptor ROR-gamma | Homo sapiens | Potency | 1496 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT1 | Others | Radical scavenging activity | Inhibition | = | 1.5 | % | 10.1007/s00044-007-9060-5 | |
NPT1175 | Organism | Spodoptera litura | Spodoptera litura | ED50 | = | 0.11 | umol/cm2 | 12517100 |
NPT1175 | Organism | Spodoptera litura | Spodoptera litura | ED50 | = | 24.6 | ug | 19342224 |
NPT587 | Tissue | Liver microsome | Rattus norvegicus | IC50 | = | 100 | ug/ml | 10.1007/s00044-012-0423-1 |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI | < | 50 | % | 10.1007/s00044-012-0423-1 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 69300 | nM | 10.1007/s00044-012-0423-1 |
NPT65 | Cell Line | HepG2 | Homo sapiens | GI50 | = | 50600 | nM | 10.1007/s00044-012-0423-1 |
NPT2562 | Individual Protein | Poly [ADP-ribose] polymerase-1 | Homo sapiens | IC50 | = | 1380.38 | nM | 23574272 |
NPT2562 | Individual Protein | Poly [ADP-ribose] polymerase-1 | Homo sapiens | IC50 | = | 1400 | nM | 23574272 |
NPT2563 | Individual Protein | Tankyrase-2 | Homo sapiens | IC50 | = | 147.91 | nM | 23574272 |
NPT2563 | Individual Protein | Tankyrase-2 | Homo sapiens | IC50 | = | 140 | nM | 23574272 |
NPT588 | Individual Protein | Tankyrase-1 | Homo sapiens | IC50 | = | 323.59 | nM | 23574272 |
NPT588 | Individual Protein | Tankyrase-1 | Homo sapiens | IC50 | = | 320 | nM | 23574272 |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 43277.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 68589.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Inhibition | < | 40 | % | 23871908 | |
NPT2 | Others | Unspecified | IC50 | = | 64900 | nM | 23871908 | |
NPT2 | Others | Unspecified | IC50 | = | 57000 | nM | 23871908 | |
NPT2 | Others | Unspecified | Activity | > | 98 | % | 23871908 | |
NPT588 | Individual Protein | Tankyrase-1 | Homo sapiens | IC50 | = | 323.59 | nM | 24116873 |
NPT588 | Individual Protein | Tankyrase-1 | Homo sapiens | IC50 | = | 330 | nM | 24116873 |
NPT570 | Individual Protein | Arachidonate 5-lipoxygenase | Homo sapiens | Inhibition | < | 50 | % | 24368208 |
NPT441 | Individual Protein | Cytochrome P450 19A1 | Homo sapiens | IC50 | = | 10000 | nM | 24345481 |
NPT2 | Others | Unspecified | Potency | 60757.8 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 27549.2 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 10896.5 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 34.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2433.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6859 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 30910.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 43651.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 17373.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 48678.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 15.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54482.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 44668.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 48990.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 22387.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5415 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12299.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 48557.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 15355.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54618.5 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 2169 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 1712.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 24336.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3833.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1933.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1722.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54967.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 153916.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 19331.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6113.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 193.8 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 9770 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 21689.9 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 18833.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 42163.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 27549.2 | nM | PubChem BioAssay data set | ||
NPT162 | Individual Protein | Heat shock protein beta-1 | Homo sapiens | Potency | 61283 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 15484.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21741.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 19379.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 30710.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61644.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 17228.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21689.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 68171.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 76958.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1087.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 858.2 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 1937.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Activity | = | 80 | % | 24793879 | |
NPT1 | Others | Radical scavenging activity | IC50 | > | 100 | ug/ml | 24793879 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Activity | = | -7.6 | % | 24793879 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 50.3 | % | 24793879 |
NPT111 | Cell Line | K562 | Homo sapiens | Activity | = | 56.8 | % | 24793879 |
NPT1 | Others | Radical scavenging activity | IC50 | = | 9590000000 | nM | 25278230 | |
NPT2 | Others | Unspecified | Inhibition | < | 40 | % | 25151578 | |
NPT2 | Others | Unspecified | Activity | = | 98 | % | 25151578 | |
NPT2 | Others | Unspecified | Potency | 48.7 | nM | PubChem BioAssay data set | ||
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | 3.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 44668.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2174.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3437.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 49 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 48672.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4366.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6875.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2169 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1712.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2730.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 35481.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 31622.8 | nM | PubChem BioAssay data set | ||
NPT441 | Individual Protein | Cytochrome P450 19A1 | Homo sapiens | IC50 | = | 8000 | nM | 26301554 |
NPT2 | Others | Unspecified | Activity | = | 102 | % | 26517554 | |
NPT2 | Others | Unspecified | Activity | = | 103 | % | 26517554 | |
NPT2 | Others | Unspecified | Activity | = | 106 | % | 26517554 | |
NPT2 | Others | Unspecified | Activity | = | 93 | % | 26517554 | |
NPT2 | Others | Unspecified | Activity | = | 92 | % | 26517554 | |
NPT2 | Others | Unspecified | Activity | = | 100 | % | 26517554 | |
NPT2 | Others | Unspecified | Activity | = | 98 | % | 26517554 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC32298 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.991 | High Similarity | NPC54243 |
0.9732 | High Similarity | NPC35744 |
0.9483 | High Similarity | NPC93730 |
0.9478 | High Similarity | NPC314329 |
0.9402 | High Similarity | NPC193805 |
0.9386 | High Similarity | NPC201284 |
0.9322 | High Similarity | NPC2771 |
0.9196 | High Similarity | NPC279916 |
0.9167 | High Similarity | NPC22783 |
0.9167 | High Similarity | NPC298884 |
0.9091 | High Similarity | NPC125887 |
0.9091 | High Similarity | NPC196034 |
0.9008 | High Similarity | NPC41721 |
0.8992 | High Similarity | NPC472888 |
0.8943 | High Similarity | NPC7569 |
0.8871 | High Similarity | NPC301717 |
0.8862 | High Similarity | NPC197425 |
0.8814 | High Similarity | NPC246214 |
0.8814 | High Similarity | NPC470092 |
0.88 | High Similarity | NPC284424 |
0.879 | High Similarity | NPC115998 |
0.879 | High Similarity | NPC278787 |
0.879 | High Similarity | NPC39753 |
0.877 | High Similarity | NPC474264 |
0.872 | High Similarity | NPC137264 |
0.872 | High Similarity | NPC141549 |
0.8696 | High Similarity | NPC53953 |
0.8689 | High Similarity | NPC224657 |
0.8661 | High Similarity | NPC57601 |
0.8661 | High Similarity | NPC292998 |
0.8655 | High Similarity | NPC230951 |
0.8651 | High Similarity | NPC113006 |
0.8651 | High Similarity | NPC278556 |
0.8644 | High Similarity | NPC171023 |
0.864 | High Similarity | NPC228184 |
0.8618 | High Similarity | NPC237868 |
0.8607 | High Similarity | NPC107846 |
0.8607 | High Similarity | NPC56332 |
0.8594 | High Similarity | NPC172262 |
0.8583 | High Similarity | NPC473655 |
0.8583 | High Similarity | NPC287533 |
0.8583 | High Similarity | NPC101294 |
0.8583 | High Similarity | NPC128216 |
0.8571 | High Similarity | NPC11173 |
0.8559 | High Similarity | NPC217423 |
0.8559 | High Similarity | NPC45104 |
0.8547 | High Similarity | NPC188907 |
0.8527 | High Similarity | NPC77955 |
0.8516 | High Similarity | NPC50898 |
0.8516 | High Similarity | NPC213216 |
0.8516 | High Similarity | NPC274121 |
0.8516 | High Similarity | NPC78540 |
0.8487 | Intermediate Similarity | NPC206007 |
0.8475 | Intermediate Similarity | NPC316062 |
0.8462 | Intermediate Similarity | NPC254741 |
0.845 | Intermediate Similarity | NPC248872 |
0.845 | Intermediate Similarity | NPC66705 |
0.845 | Intermediate Similarity | NPC125269 |
0.8443 | Intermediate Similarity | NPC311219 |
0.8413 | Intermediate Similarity | NPC187907 |
0.8413 | Intermediate Similarity | NPC473019 |
0.8403 | Intermediate Similarity | NPC469954 |
0.84 | Intermediate Similarity | NPC49852 |
0.84 | Intermediate Similarity | NPC475496 |
0.8397 | Intermediate Similarity | NPC228661 |
0.8397 | Intermediate Similarity | NPC266597 |
0.8397 | Intermediate Similarity | NPC157855 |
0.8397 | Intermediate Similarity | NPC299379 |
0.8397 | Intermediate Similarity | NPC250266 |
0.8397 | Intermediate Similarity | NPC103001 |
0.8387 | Intermediate Similarity | NPC4164 |
0.8385 | Intermediate Similarity | NPC239495 |
0.8385 | Intermediate Similarity | NPC9985 |
0.8374 | Intermediate Similarity | NPC182646 |
0.8362 | Intermediate Similarity | NPC23332 |
0.8359 | Intermediate Similarity | NPC472882 |
0.8359 | Intermediate Similarity | NPC474340 |
0.8347 | Intermediate Similarity | NPC168050 |
0.8333 | Intermediate Similarity | NPC152159 |
0.8333 | Intermediate Similarity | NPC473907 |
0.8321 | Intermediate Similarity | NPC61546 |
0.8321 | Intermediate Similarity | NPC29353 |
0.8321 | Intermediate Similarity | NPC124784 |
0.8321 | Intermediate Similarity | NPC47815 |
0.8321 | Intermediate Similarity | NPC473887 |
0.8321 | Intermediate Similarity | NPC256042 |
0.8321 | Intermediate Similarity | NPC216361 |
0.8321 | Intermediate Similarity | NPC161196 |
0.8321 | Intermediate Similarity | NPC72452 |
0.8321 | Intermediate Similarity | NPC194281 |
0.8321 | Intermediate Similarity | NPC231772 |
0.8321 | Intermediate Similarity | NPC116775 |
0.8321 | Intermediate Similarity | NPC281917 |
0.8321 | Intermediate Similarity | NPC13408 |
0.8321 | Intermediate Similarity | NPC234133 |
0.8321 | Intermediate Similarity | NPC187432 |
0.8321 | Intermediate Similarity | NPC127447 |
0.8319 | Intermediate Similarity | NPC470860 |
0.8295 | Intermediate Similarity | NPC182428 |
0.8295 | Intermediate Similarity | NPC229646 |
0.8276 | Intermediate Similarity | NPC183648 |
0.8271 | Intermediate Similarity | NPC136095 |
0.8268 | Intermediate Similarity | NPC211120 |
0.8268 | Intermediate Similarity | NPC473894 |
0.8268 | Intermediate Similarity | NPC57552 |
0.8268 | Intermediate Similarity | NPC238309 |
0.8264 | Intermediate Similarity | NPC43435 |
0.8258 | Intermediate Similarity | NPC476480 |
0.8258 | Intermediate Similarity | NPC275055 |
0.8258 | Intermediate Similarity | NPC84585 |
0.8258 | Intermediate Similarity | NPC290291 |
0.8244 | Intermediate Similarity | NPC99854 |
0.8231 | Intermediate Similarity | NPC223354 |
0.8226 | Intermediate Similarity | NPC11799 |
0.8226 | Intermediate Similarity | NPC141252 |
0.8209 | Intermediate Similarity | NPC475680 |
0.8209 | Intermediate Similarity | NPC270883 |
0.8209 | Intermediate Similarity | NPC172986 |
0.8209 | Intermediate Similarity | NPC472409 |
0.8209 | Intermediate Similarity | NPC281207 |
0.8209 | Intermediate Similarity | NPC269652 |
0.8209 | Intermediate Similarity | NPC235239 |
0.8209 | Intermediate Similarity | NPC261227 |
0.8209 | Intermediate Similarity | NPC305355 |
0.8205 | Intermediate Similarity | NPC233238 |
0.8197 | Intermediate Similarity | NPC233282 |
0.8195 | Intermediate Similarity | NPC188947 |
0.8195 | Intermediate Similarity | NPC329225 |
0.8195 | Intermediate Similarity | NPC18457 |
0.8195 | Intermediate Similarity | NPC99333 |
0.8195 | Intermediate Similarity | NPC17848 |
0.8195 | Intermediate Similarity | NPC276905 |
0.8195 | Intermediate Similarity | NPC147686 |
0.8195 | Intermediate Similarity | NPC201395 |
0.8195 | Intermediate Similarity | NPC472460 |
0.8195 | Intermediate Similarity | NPC280284 |
0.8189 | Intermediate Similarity | NPC475017 |
0.8182 | Intermediate Similarity | NPC240593 |
0.8174 | Intermediate Similarity | NPC141523 |
0.8168 | Intermediate Similarity | NPC298900 |
0.8158 | Intermediate Similarity | NPC139891 |
0.8151 | Intermediate Similarity | NPC252004 |
0.8148 | Intermediate Similarity | NPC136840 |
0.8148 | Intermediate Similarity | NPC147688 |
0.8148 | Intermediate Similarity | NPC64908 |
0.8148 | Intermediate Similarity | NPC156590 |
0.8148 | Intermediate Similarity | NPC118840 |
0.8148 | Intermediate Similarity | NPC24075 |
0.8148 | Intermediate Similarity | NPC103362 |
0.8148 | Intermediate Similarity | NPC205006 |
0.8148 | Intermediate Similarity | NPC110969 |
0.814 | Intermediate Similarity | NPC270369 |
0.814 | Intermediate Similarity | NPC324488 |
0.814 | Intermediate Similarity | NPC5515 |
0.8134 | Intermediate Similarity | NPC220062 |
0.8134 | Intermediate Similarity | NPC216978 |
0.8134 | Intermediate Similarity | NPC152042 |
0.8134 | Intermediate Similarity | NPC18260 |
0.8134 | Intermediate Similarity | NPC301217 |
0.8134 | Intermediate Similarity | NPC261234 |
0.8134 | Intermediate Similarity | NPC241838 |
0.8134 | Intermediate Similarity | NPC143799 |
0.8134 | Intermediate Similarity | NPC78913 |
0.8134 | Intermediate Similarity | NPC55018 |
0.8134 | Intermediate Similarity | NPC11566 |
0.8134 | Intermediate Similarity | NPC96565 |
0.8134 | Intermediate Similarity | NPC303633 |
0.812 | Intermediate Similarity | NPC160972 |
0.812 | Intermediate Similarity | NPC295261 |
0.812 | Intermediate Similarity | NPC13768 |
0.812 | Intermediate Similarity | NPC107586 |
0.812 | Intermediate Similarity | NPC79943 |
0.812 | Intermediate Similarity | NPC296490 |
0.812 | Intermediate Similarity | NPC188879 |
0.812 | Intermediate Similarity | NPC287246 |
0.812 | Intermediate Similarity | NPC259685 |
0.812 | Intermediate Similarity | NPC32441 |
0.812 | Intermediate Similarity | NPC12296 |
0.812 | Intermediate Similarity | NPC243083 |
0.812 | Intermediate Similarity | NPC254841 |
0.8115 | Intermediate Similarity | NPC264976 |
0.811 | Intermediate Similarity | NPC470841 |
0.811 | Intermediate Similarity | NPC264428 |
0.811 | Intermediate Similarity | NPC45537 |
0.811 | Intermediate Similarity | NPC161322 |
0.8106 | Intermediate Similarity | NPC46869 |
0.8106 | Intermediate Similarity | NPC234560 |
0.8106 | Intermediate Similarity | NPC39426 |
0.8106 | Intermediate Similarity | NPC151113 |
0.8106 | Intermediate Similarity | NPC472881 |
0.8106 | Intermediate Similarity | NPC324929 |
0.8103 | Intermediate Similarity | NPC224584 |
0.8095 | Intermediate Similarity | NPC165556 |
0.8095 | Intermediate Similarity | NPC470858 |
0.8095 | Intermediate Similarity | NPC65041 |
0.8092 | Intermediate Similarity | NPC1249 |
0.8088 | Intermediate Similarity | NPC226636 |
0.8088 | Intermediate Similarity | NPC1534 |
0.8088 | Intermediate Similarity | NPC11561 |
0.8077 | Intermediate Similarity | NPC475589 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC32298 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9478 | High Similarity | NPD1547 | Clinical (unspecified phase) |
0.879 | High Similarity | NPD2313 | Discontinued |
0.877 | High Similarity | NPD2798 | Approved |
0.8689 | High Similarity | NPD1203 | Approved |
0.8629 | High Similarity | NPD6832 | Phase 2 |
0.8534 | High Similarity | NPD1241 | Discontinued |
0.8462 | Intermediate Similarity | NPD2796 | Approved |
0.8443 | Intermediate Similarity | NPD9717 | Approved |
0.8295 | Intermediate Similarity | NPD1933 | Approved |
0.8244 | Intermediate Similarity | NPD2799 | Discontinued |
0.824 | Intermediate Similarity | NPD3267 | Approved |
0.824 | Intermediate Similarity | NPD3266 | Approved |
0.8217 | Intermediate Similarity | NPD4307 | Phase 2 |
0.8195 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8175 | Intermediate Similarity | NPD1019 | Discontinued |
0.8158 | Intermediate Similarity | NPD9697 | Approved |
0.8154 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.812 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.812 | Intermediate Similarity | NPD2344 | Approved |
0.812 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.812 | Intermediate Similarity | NPD2346 | Discontinued |
0.8106 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8106 | Intermediate Similarity | NPD3748 | Approved |
0.8095 | Intermediate Similarity | NPD2797 | Approved |
0.8077 | Intermediate Similarity | NPD1240 | Approved |
0.8 | Intermediate Similarity | NPD3972 | Approved |
0.7971 | Intermediate Similarity | NPD5401 | Approved |
0.797 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7955 | Intermediate Similarity | NPD1607 | Approved |
0.7923 | Intermediate Similarity | NPD3268 | Approved |
0.791 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7899 | Intermediate Similarity | NPD1511 | Approved |
0.7883 | Intermediate Similarity | NPD2309 | Approved |
0.7874 | Intermediate Similarity | NPD1876 | Approved |
0.7869 | Intermediate Similarity | NPD9493 | Approved |
0.7868 | Intermediate Similarity | NPD1243 | Approved |
0.7857 | Intermediate Similarity | NPD5403 | Approved |
0.7852 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7842 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7842 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7826 | Intermediate Similarity | NPD9261 | Approved |
0.781 | Intermediate Similarity | NPD3750 | Approved |
0.7786 | Intermediate Similarity | NPD411 | Approved |
0.7786 | Intermediate Similarity | NPD1512 | Approved |
0.777 | Intermediate Similarity | NPD6799 | Approved |
0.776 | Intermediate Similarity | NPD17 | Approved |
0.7754 | Intermediate Similarity | NPD3295 | Clinical (unspecified phase) |
0.7744 | Intermediate Similarity | NPD447 | Suspended |
0.7737 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7734 | Intermediate Similarity | NPD3225 | Approved |
0.7714 | Intermediate Similarity | NPD4662 | Approved |
0.7714 | Intermediate Similarity | NPD4661 | Approved |
0.7698 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD2935 | Discontinued |
0.7638 | Intermediate Similarity | NPD1201 | Approved |
0.7622 | Intermediate Similarity | NPD3226 | Approved |
0.7603 | Intermediate Similarity | NPD1609 | Clinical (unspecified phase) |
0.76 | Intermediate Similarity | NPD1894 | Discontinued |
0.7591 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7589 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7586 | Intermediate Similarity | NPD6844 | Discontinued |
0.7581 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7578 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7578 | Intermediate Similarity | NPD1608 | Approved |
0.7569 | Intermediate Similarity | NPD6585 | Discontinued |
0.7565 | Intermediate Similarity | NPD1238 | Approved |
0.7563 | Intermediate Similarity | NPD9264 | Approved |
0.7563 | Intermediate Similarity | NPD9267 | Approved |
0.7563 | Intermediate Similarity | NPD9263 | Approved |
0.7541 | Intermediate Similarity | NPD5535 | Approved |
0.7538 | Intermediate Similarity | NPD1470 | Approved |
0.7537 | Intermediate Similarity | NPD3140 | Approved |
0.7537 | Intermediate Similarity | NPD3142 | Approved |
0.7517 | Intermediate Similarity | NPD5890 | Approved |
0.7517 | Intermediate Similarity | NPD7411 | Suspended |
0.7517 | Intermediate Similarity | NPD5889 | Approved |
0.75 | Intermediate Similarity | NPD74 | Approved |
0.75 | Intermediate Similarity | NPD9266 | Approved |
0.75 | Intermediate Similarity | NPD1535 | Discovery |
0.7483 | Intermediate Similarity | NPD5402 | Approved |
0.7483 | Intermediate Similarity | NPD920 | Approved |
0.7466 | Intermediate Similarity | NPD6801 | Discontinued |
0.7464 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7464 | Intermediate Similarity | NPD2353 | Approved |
0.7448 | Intermediate Similarity | NPD6599 | Discontinued |
0.7448 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7429 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7415 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7415 | Intermediate Similarity | NPD7819 | Suspended |
0.7415 | Intermediate Similarity | NPD2801 | Approved |
0.7402 | Intermediate Similarity | NPD1651 | Approved |
0.7388 | Intermediate Similarity | NPD6798 | Discontinued |
0.7388 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7383 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7353 | Intermediate Similarity | NPD4622 | Approved |
0.7353 | Intermediate Similarity | NPD4618 | Approved |
0.7347 | Intermediate Similarity | NPD6280 | Approved |
0.7347 | Intermediate Similarity | NPD6279 | Approved |
0.7347 | Intermediate Similarity | NPD1934 | Approved |
0.7333 | Intermediate Similarity | NPD968 | Approved |
0.7323 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7319 | Intermediate Similarity | NPD7033 | Discontinued |
0.7297 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7286 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD1164 | Approved |
0.7267 | Intermediate Similarity | NPD3749 | Approved |
0.7267 | Intermediate Similarity | NPD7075 | Discontinued |
0.7266 | Intermediate Similarity | NPD5585 | Approved |
0.7259 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7254 | Intermediate Similarity | NPD2354 | Approved |
0.7254 | Intermediate Similarity | NPD3887 | Approved |
0.7248 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD2296 | Approved |
0.7246 | Intermediate Similarity | NPD5688 | Approved |
0.7246 | Intermediate Similarity | NPD5689 | Approved |
0.7244 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7231 | Intermediate Similarity | NPD1281 | Approved |
0.7231 | Intermediate Similarity | NPD422 | Phase 1 |
0.7226 | Intermediate Similarity | NPD1184 | Approved |
0.7203 | Intermediate Similarity | NPD7440 | Discontinued |
0.72 | Intermediate Similarity | NPD3882 | Suspended |
0.72 | Intermediate Similarity | NPD7768 | Phase 2 |
0.719 | Intermediate Similarity | NPD3134 | Approved |
0.7188 | Intermediate Similarity | NPD9545 | Approved |
0.7183 | Intermediate Similarity | NPD7003 | Approved |
0.7183 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7172 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7171 | Intermediate Similarity | NPD5494 | Approved |
0.7162 | Intermediate Similarity | NPD2366 | Approved |
0.7143 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD9281 | Approved |
0.7132 | Intermediate Similarity | NPD3764 | Approved |
0.7131 | Intermediate Similarity | NPD1358 | Approved |
0.7131 | Intermediate Similarity | NPD290 | Approved |
0.713 | Intermediate Similarity | NPD1202 | Approved |
0.7105 | Intermediate Similarity | NPD919 | Approved |
0.7101 | Intermediate Similarity | NPD6355 | Discontinued |
0.7099 | Intermediate Similarity | NPD1611 | Approved |
0.7097 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7087 | Intermediate Similarity | NPD2557 | Approved |
0.708 | Intermediate Similarity | NPD6233 | Phase 2 |
0.708 | Intermediate Similarity | NPD8032 | Phase 2 |
0.7077 | Intermediate Similarity | NPD1778 | Approved |
0.7068 | Intermediate Similarity | NPD1283 | Approved |
0.7055 | Intermediate Similarity | NPD6273 | Approved |
0.7042 | Intermediate Similarity | NPD2897 | Discontinued |
0.7029 | Intermediate Similarity | NPD943 | Approved |
0.7027 | Intermediate Similarity | NPD2651 | Approved |
0.7027 | Intermediate Similarity | NPD2649 | Approved |
0.7025 | Intermediate Similarity | NPD1237 | Approved |
0.7023 | Intermediate Similarity | NPD3496 | Discontinued |
0.7021 | Intermediate Similarity | NPD4476 | Approved |
0.7021 | Intermediate Similarity | NPD4477 | Approved |
0.702 | Intermediate Similarity | NPD5616 | Clinical (unspecified phase) |
0.702 | Intermediate Similarity | NPD4288 | Approved |
0.7016 | Intermediate Similarity | NPD5451 | Approved |
0.7013 | Intermediate Similarity | NPD1247 | Approved |
0.7007 | Intermediate Similarity | NPD3869 | Phase 3 |
0.7007 | Intermediate Similarity | NPD3873 | Phase 3 |
0.7007 | Intermediate Similarity | NPD5586 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD3818 | Discontinued |
0.7 | Intermediate Similarity | NPD7317 | Phase 3 |
0.6993 | Remote Similarity | NPD2654 | Approved |
0.6993 | Remote Similarity | NPD2800 | Approved |
0.6993 | Remote Similarity | NPD3252 | Approved |
0.6992 | Remote Similarity | NPD4359 | Approved |
0.6987 | Remote Similarity | NPD7852 | Clinical (unspecified phase) |
0.6985 | Remote Similarity | NPD1008 | Clinical (unspecified phase) |
0.6985 | Remote Similarity | NPD2614 | Approved |
0.697 | Remote Similarity | NPD1610 | Phase 2 |
0.6968 | Remote Similarity | NPD6808 | Phase 2 |
0.6966 | Remote Similarity | NPD160 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD4062 | Phase 3 |
0.6953 | Remote Similarity | NPD6671 | Approved |
0.6935 | Remote Similarity | NPD2684 | Approved |
0.6928 | Remote Similarity | NPD955 | Approved |
0.6923 | Remote Similarity | NPD2486 | Discontinued |
0.6923 | Remote Similarity | NPD3926 | Phase 2 |
0.6913 | Remote Similarity | NPD7458 | Discontinued |
0.6912 | Remote Similarity | NPD9494 | Approved |
0.6912 | Remote Similarity | NPD454 | Approved |
0.6908 | Remote Similarity | NPD7318 | Phase 3 |
0.6901 | Remote Similarity | NPD6099 | Approved |
0.6901 | Remote Similarity | NPD6100 | Approved |
0.6894 | Remote Similarity | NPD3847 | Discontinued |
0.6887 | Remote Similarity | NPD7577 | Discontinued |
0.6885 | Remote Similarity | NPD5909 | Discontinued |
0.6885 | Remote Similarity | NPD164 | Approved |
0.6879 | Remote Similarity | NPD6166 | Phase 2 |
0.6879 | Remote Similarity | NPD6168 | Clinical (unspecified phase) |
0.6879 | Remote Similarity | NPD6167 | Clinical (unspecified phase) |
0.687 | Remote Similarity | NPD5691 | Approved |
0.687 | Remote Similarity | NPD3049 | Approved |
0.687 | Remote Similarity | NPD3445 | Approved |
0.687 | Remote Similarity | NPD3443 | Approved |
0.687 | Remote Similarity | NPD3444 | Approved |
0.6866 | Remote Similarity | NPD4379 | Clinical (unspecified phase) |
0.6855 | Remote Similarity | NPD7804 | Clinical (unspecified phase) |
0.6855 | Remote Similarity | NPD9265 | Clinical (unspecified phase) |
PubChem CID   | 10680 |
ChEMBL   | CHEMBL275638 |
ZINC   |
Molecular Weight:   | 222.07 |
ALogP:   | -0.5036 |
MLogP:   | 2.89 |
XLogP:   | 5.3 |
# Rotatable Bonds:   | 1 |
Polar Surface Area:   | 26.3 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 17 |